Prime Medicine (PRME) FCF Margin (2024 - 2026)

Prime Medicine (PRME) reported FCF Margin of 5014.49% for Q1 2026, down 148773.0% on a YoY basis from N/an in Q1 2025, and down 26.84% quarter-over-quarter from 3953.34% in Q4 2025.

Prime Medicine (PRME) FCF Margin (2024 - 2026) Analysis & Trends

Prime Medicine has reported FCF Margin for 3 years, with the latest figure at 5014.49% in Q1 2026.

  • For the quarter ending Q1 2026, FCF Margin fell 148773.0% year-over-year to 5014.49%; the trailing twelve-month figure through Mar 2026 stood at 3825.56% (down 108851.0% YoY), and the FY2025 full-year result was 3512.05%, up 64548.0% from the prior year.
  • FCF Margin for Q1 2026 stood at 5014.49%, down from 3953.34% in the prior quarter.
  • The five-year high for FCF Margin was 696.38% in Q4 2024, with the low at 12281.34% in Q3 2024.
  • Historically, FCF Margin has averaged 5329.21% across 3 years, with a median of 3740.05% in 2025.
  • The largest YoY upside for FCF Margin was 908689 bps in 2025 against a maximum downside of 464972 bps in 2025.
  • Prime Medicine's FCF Margin stood at 696.38% in 2024, then tumbled by 668 bps to 3953.34% in 2025, then slipped by 27 bps to 5014.49% in 2026.
  • The last three FCF Margin figures came in at 5014.49% (Q1 2026), 3953.34% (Q4 2025), and 3194.45% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -3.98%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 43.35%
9 Abivax 91.96 Bn 91.96 Bn - -
10 Prime Medicine 572.02 Mn 572.02 Mn - -5,014.49%

Historic Data

Download Data
DateValue
Mar 31, 2026 -5,014.49%
Dec 31, 2025 -3,953.34%
Sep 30, 2025 -3,194.45%
Jun 30, 2025 -3,510.13%
Mar 31, 2025 -3,526.75%
Dec 31, 2024 696.38%
Sep 30, 2024 -12,281.34%
Mar 31, 2024 -11,849.58%